Malignant Pleural Mesothelioma Outcomes in the Era of Combined Platinum and Folate Antimetabolite Chemotherapy.

Saint-Pierre, Mathieu D; Pease, Christopher; Mithoowani, Hamid; Zhang, Tinghua; Nicholas, Garth A; Laurie, Scott A; Wheatley-Price, Paul

Saint-Pierre, Mathieu D; Pease, Christopher; Mithoowani, Hamid; Zhang, Tinghua; Nicholas, Garth A; Laurie, Scott A; Wheatley-Price, Paul.

Afiliação

Saint-Pierre MD; Department of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6 ; Department of Medicine, Queen's University, 102 Stuart Street, Kingston, ON, Canada K7L 2V6.
Pease C; Department of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6.
Mithoowani H; Department of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6.
Zhang T; The Ottawa Hospital Research Institute, 725 Parkdale Avenue, Ottawa, ON, Canada K1Y 4E9.
Nicholas GA; Department of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6.
Laurie SA; Department of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6.
Wheatley-Price P; Department of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6.

Lung Cancer Int ; 2015: 590148, 2015.

Article em En | MEDLINE | ID: mdl-26316950

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Lung Cancer Int Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google